Curiox BioSystems Co Ltd
KOSDAQ:445680
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13 440
119 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Curiox BioSystems Co Ltd
Cash from Operating Activities
Curiox BioSystems Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Curiox BioSystems Co Ltd
KOSDAQ:445680
|
Cash from Operating Activities
-â‚©9.7B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Cash from Operating Activities
â‚©10.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-8%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cash from Operating Activities
â‚©106B
|
CAGR 3-Years
42%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Cash from Operating Activities
â‚©31.2B
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
InBody Co Ltd
KOSDAQ:041830
|
Cash from Operating Activities
â‚©27.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Cash from Operating Activities
-â‚©11.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Curiox BioSystems Co Ltd
Glance View
Curiox BioSystems Co Ltd is a KR-based company operating in industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2023-08-10. Curiox BioSystems Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of automation equipment and consumables for cell analysis processes. The firm is engaged in the manufacture and sale of cell pretreatment automation devices, washing machines, plates and other products. In addition, the Company is engaged in the manufacture and sale of high-capacity adapters, strip spacers, buffer exchanger products and others.
See Also
What is Curiox BioSystems Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-9.7B
KRW
Based on the financial report for Dec 31, 2024, Curiox BioSystems Co Ltd's Cash from Operating Activities amounts to -9.7B KRW.
What is Curiox BioSystems Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-24%
Over the last year, the Cash from Operating Activities growth was -19%. The average annual Cash from Operating Activities growth rates for Curiox BioSystems Co Ltd have been -24% over the past three years .